Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Colorectal Cancer”

501 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 501 results

Testing effectiveness (Phase 2)Looking for participantsNCT07140679
What this trial is testing

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Who this might be right for
Localized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more
Emory University 40
Testing effectiveness (Phase 2)Study completedNCT03666442
What this trial is testing

Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 61
Not applicableStudy completedNCT07104903
What this trial is testing

Risk Factor Assessment for the Development of Surgical Site Infection in Patients Undergoing Colorectal Cancer Surgery

Who this might be right for
Surgical Site InfectionsColorectal Cancer
Oncology Institute of Vojvodina 62
Not applicableStudy completedNCT02481219
What this trial is testing

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

Who this might be right for
Colorectal Cancer Screening
Medtronic - MITG 122
Not applicableLooking for participantsNCT07498829
What this trial is testing

Population Based Germline Testing for Early Detection and Prevention of Cancer

Who this might be right for
Breast Cancer RiskOvarian Cancer RiskCancer Gene Mutation
Queen Mary University of London 6,000
Testing effectiveness (Phase 2)UnknownNCT06120127
What this trial is testing

Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

Who this might be right for
RadiotherapyImmunotherapyLiver Metastases+1 more
Fudan University 80
Large-scale testing (Phase 3)UnknownNCT04134897
What this trial is testing

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer

Who this might be right for
Rectal Neoplasms MalignantRectum CarcinomaRectal Cancer
Blokhin's Russian Cancer Research Center 316
Testing effectiveness (Phase 2)Study completedNCT00003544
What this trial is testing

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT03031444
What this trial is testing

Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis

Who this might be right for
Colorectal Cancer Stage IVMetastasis
Peking University Cancer Hospital & Institute 135
Not applicableEnded earlyNCT02503111
What this trial is testing

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Who this might be right for
Anal DysplasiaHuman PapillomavirusAnal Cancer
University Health Network, Toronto 71
Not applicableStudy completedNCT04606992
What this trial is testing

Combined Endoscopic and Laparoscopic Surgery (CELS) for Early Colon Cancer in High Risk Patients

Who this might be right for
Colon Cancer Stage I
Zealand University Hospital 25
Not applicableStudy completedNCT02368236
What this trial is testing

Facilitating Risk-Appropriate Colorectal Cancer Testing - Testing the Cancer Risk Intake System (CRIS)

Who this might be right for
Colorectal NeoplasmsColonic Neoplasms
University of Texas Southwestern Medical Center 1,012
Not applicableStudy completedNCT01104181
What this trial is testing

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

Who this might be right for
Anal Canal HPV Infection DiagnosisAnal Dysplasia DiagnosisAnal Cancer
Laser Surgery Care 300
Not applicableEnrolling By InvitationNCT06868095
What this trial is testing

Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.

Who this might be right for
Colorectal CancerEarly Onset Colorectal CancerSarcopenia+3 more
Instituto de Investigación Biomédica de Salamanca 1,000
Not applicableStudy completedNCT04287335
What this trial is testing

Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China

Who this might be right for
Colorectal CancerAdenomatous PolypsAdenoma+1 more
Zhejiang University 4,758
Not applicableStudy completedNCT03364582
What this trial is testing

Dietary Patterns, Metabolomics and Colorectal Cancer Risk

Who this might be right for
Colorectal CancerMortality
Ohio State University Comprehensive Cancer Center 173,230
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Testing effectiveness (Phase 2)Temporarily pausedNCT07071961
What this trial is testing

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Who this might be right for
Colorectal CancerRegorafenibHigh Risk Patients
M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT00812942
What this trial is testing

Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy

Who this might be right for
Colorectal Cancer
Istituto Superiore di Sanità 9,889
Large-scale testing (Phase 3)Looking for participantsNCT06229041
What this trial is testing

Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 472
Load More Results